Teva Pharmaceutical Industries Limited (FRA:TEV)

Market Cap	31.57B
Revenue (ttm)	14.30B
Net Income (ttm)	607.69M
Shares Out	n/a
EPS (ttm)	0.53
PE Ratio	51.95
Forward PE	12.14
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,055
Average Volume	3,482
Open	27.50
Previous Close	27.90
Day's Range	27.10 - 28.40
52-Week Range	11.15 - 28.40
Beta	n/a
RSI	75.54
Earnings Date	Jan 28, 2026

About FRA:TEV

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 35,686
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TEV

Financial Performance

In 2024, FRA:TEV's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.

Financial numbers in USD